The idea behind this paper is to take an economics or business perspective from the social sciences and look at the venture capital landscape for companies, which through their value propositions are producing, or enabling the development of digital biomarkers. This is in particular interesting as it entails the wearables market, which is innovative and fast moving in itself as well as the platform and health app providers.